Spanish Lab Secures Contract to Make Coronavirus Vaccine

Moderna and Rovi have signed a collaboration agreement for the large-scale manufacture of the modern mRNA candidate vaccine against Covid-19 which will be produced at the Rovi facilities in Madrid, Spain.

THE Moderna Chief Technology Operations and Quality Officer, Juan Andres, has announced that “Moderna is committed to helping address the Covid-19 crisis. We are pleased to partner with Rovi to potentially deliver hundreds of millions of doses of the finished mRNA-1273 vaccine, once it is approved, and help address the need for a vaccine against Covid-19 worldwide.”

As part of the agreement, Rovi will fill the vials and acquire a new production line as well as the equipment for the formulation, filling, automatic visual inspection and labelling to support the production of hundreds of millions of doses of the candidate vaccine if all goes to plan.

In principle, this will serve to supply markets outside the United States as early as 2021. Rovi will also hire additional personnel to carry out manufacturing and production operations.

The lab has assured, “Rovi’s experience as a global manufacturer of pharmaceuticals and its expertise in filling and finishing will be an important collaboration for us in establishing dedicated supply chains that can meet the needs of different countries and regions.”